You are here: Industry Insights > Syngene

News List

Syngene expands biopharma-manufacturing capacity expresspharma
August 13, 2021
The company sets up a state-of-the-art microbial facility; expands mammalian facility.
Syngene Adds Senior Leadership in the U.S. contractpharma
August 09, 2021
Alex Del Priore appointed Senior Vice President, Manufacturing Services, and Alan Collis appointed Vice President, Integrated Drug Discovery Services.
Syngene appoints two senior leaders in US expresspharma
August 05, 2021
While Alex Del Priore has been appointed as Senior Vice President, Manufacturing Services; Alan Collis has been appointed as Vice President, Integrated Drug Discovery Services.
Syngene appoints Sanjeev Sukumaran as CHRO expresspharma
June 09, 2021
Sukumaran joined Syngene in October 2017 as the Chief of Staff and was responsible for driving key strategic initiatives across the organisation.
Dyadic Collaborates with Syngene to Develop Covid-19 Vaccine Candidate contractpharma
May 27, 2021
Dyadic International Inc. a global biotechnology company, has entered into a collaboration with Syngene International Limited, an integrated research, development, and manufacturing services company, to develop a COVID-19 vaccine candidate that can ...
Syngene extends research partnership with Bristol Myers Squibb until 2030 expresspharma
April 28, 2021
The extension envisions a 40 per cent increase in the number of scientists and the addition of a new 50,000 sq. ft. dedicated laboratory space.
Syngene and 3DC Sign 5-year Collaboration contractpharma
November 25, 2020
Partner on discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.
Syngene and Deerfield Discovery and Development partner to advance therapeutic discovery projects expresspharma
November 20, 2020
It is a five-year strategic collaboration which will start with immediate effect.
Syngene announces Q1 FY21 results; Revenue stands at Rs. 437 Cr expresspharma
July 24, 2020
The company posted quarterly revenue of Rs. 437 Cr, in line with guidance: Profit After Tax, was impacted less than expected, at Rs. 58 Cr for the quarter.
Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19 expresspharma
June 04, 2020
Syngene International, an integrated research and development services company, has entered into collaboration with HiMedia Laboratories for over 45 years, to manufacture and distribute its ELISA kits.

Previous page 1 2 Next page